Status:
COMPLETED
Estrogen Pretreatment Prior to GnRH Antagonist Protocol
Lead Sponsor:
Gemer
Conditions:
Infertility
Eligibility:
FEMALE
18-38 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess whether estrogen pre-treatment can allow retrieval of 2 additional oocytes in GnRH antagonist protocol.
Eligibility Criteria
Inclusion
- regular normo-ovulatory cycles (28 to 35 days)
- age \< 38 years,
- body mass index (BMI) between 18 and 30
- first or second IVF/ICSI attempt
Exclusion
- high basal levels of serum FSH or E2,
- less than 5 follicles at the antral follicular count performed on day 3 of a spontaneous cycle,
- history of high (\>20 oocytes) or low (\< 5 oocytes) ovarian response in a previous IVF attempt
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT01489852
Start Date
December 1 2006
End Date
May 1 2011
Last Update
December 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Medecine de la Reproduction, Hôpital Jean Verdier
Bondy, Île-de-France Region, France, 93140